CClinicalTrials.gg
RecruitingNCT06088108Updated Oct 18, 2023

Metabolic Responses to Exercise and Recovery

An interventional study of Cornell treadmill exercise protocol in Exercise and Metabolism, sponsored by University College, London. Recruiting at 1 site in United Kingdom. Open to participants aged 8 Years to 57 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-18.

Sponsored by University College, London · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 8 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Apr 2023, registered Oct 2023).
  • Started Apr 2023; still recruiting 3 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Not applicable
Ages
8 Years to 57 Years
Sex
All
01

Study summary

Exercise benefits health through diverse metabolic processes and is central to healthy ageing. However, intense exercise also challenges the body, causing cellular damage that must be repaired. This means that we need to identify the level of exercise that can optimise health, and this level might potentially differ by age and sex. Our research aims to tackle this question, by studying the metabolic responses of the body both to exercise and during the subsequent recovery in 48 healthy and active participants between the ages of 8-10, 23-27 and 53-57.

Participants will complete an inclusion questionnaire and, if eligible, be invited to visit the exercise laboratory 4-5-hours. We will collect questionnaire data and body measurements before participants undertake exercise on a treadmill. Biological samples (blood from adults only and saliva from everyone) will be collected at three time points (before, right after and one hour after exercise).

Read the detailed description

Before taking part, participants will be asked to complete an online inclusion questionnaire where the investigators will ask some questions about their health status, weight status, lifestyle, and medications to confirm that the participants are eligible and that it is safe for the participants to participate in the study. The investigators will record their consent electronically at this stage. If the participants are eligible and decide to take part in the study, the investigators will ask the participants to record their consent in writing before proceeding further.

The in-person part of the study will take place at the University Of East London SportsDock (4-6 University Way, London E16 2RD) and last 4-5 hours. No breakfast or coffee/tea should be consumed on the day of the visit, but the investigators will offer the participants breakfast. The participants will also need to not have had any alcohol, recreational drugs, or exercise for 24 hours.

On the day, the investigators will first measure their resting heart rate and blood pressure, collect body measurements (weight, height, waist circumference, hip circumference), and measure their body composition. The last thing the investigators will do before breakfast is to collect some samples. The investigators will collect two separate saliva samples using synthetic cotton swabs. After this, the investigators will collect a blood sample by venepuncture ("needle prick") from the adults only. This first part of the study will take 45-60 minutes.

Along with breakfast, the investigators will ask the participants to consume a dose of deuterium-labelled water: an odourless, tasteless, and safe water that will allow us to measure their total body water content. The investigators will also ask the participants to complete two short questionnaires assessing their mood, appetite, feeling of tiredness as well as verbal learning. This part will take approximately 30 minutes.

The researcher will then help the participants familiarise with the treadmill and associated equipment. The participants will wear a chest strap under their clothes and a special face mask which will be held in place by a head strap. These will measure their heart rate and everything the participants breathe in and out throughout the exercise challenge, respectively. The treadmill will start slowly to help the participants warm up and familiarise with the feeling of walking on it. After 2 minutes, the exercise challenge will begin. This will last for approximately 20 minutes, during which the treadmill will increase the speed and/or the incline every 2 minutes. It will feel like the participants are walking more briskly and more uphill, but it will not be too fast. The researcher will encourage the participants to complete the exercise challenge, as this will get the best response from their metabolism and give us the most accurate results. The participants will be able to stop the treadmill if the participants feel too exhausted to continue, feel faint or develop chest pain.

Right after the participants complete the exercise challenge, the investigators will collect a saliva sample using a synthetic cotton swab and a blood sample by venepuncture (adults only). The investigators will then ask the participants to complete the same two short questionnaires as before. This part will take approximately 30 minutes.

Finally, the researcher will allow the participants to relax and rest for about an hour. The investigators will then collect the last saliva samples using synthetic cotton swabs and blood samples by venepuncture (adults only). The participants will then complete the last iteration of the two short questionnaires.

02

Conditions studied

  • Exercise
  • Metabolism

Keywords

  • Exercise
  • Metabolism
  • Recovery
  • Metabolomics
03

In context

Lead sponsor

University College, London is the lead sponsor of 632 studies on the registry; 145 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 57 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Aged 8-10, 23-27 or 53-57
  2. Considered healthy without a disease, disability or other condition that would impair participation in physical activity.
  3. Considered active.
  4. A body mass index within the ranges of 19 to 24.5 (adults) or the 2nd and 99th percentile (children)

Exclusion criteria

Exclusion Criteria:

  1. Outside required age brackets
  2. Having a disease, disability or other condition that would impair participation in physical activity.
  3. Having an implanted cardiac pacemaker, defibrillator, or other electronic medical devices.
  4. Receiving prescription medication one or more days every week over the past 3 months (some medications are permitted).
  5. Related by blood to another participant.
  6. Not willing at the time of recruitment to undergo blood sampling (adults only).
  7. Pregnancy/breastfeeding (adults only).
  8. Being a professional athlete.
  9. Not being physically active.
  10. Being a shift worker (night shift work for three or more days per week on more than two occasions in the six months before the visit day; adults only).
  11. Recent weight loss of more than 5% of weight in the last 6 months.
  12. Having a body mass index outside the range of 19 to 24.5 (adults) or outside the 2nd and 99th percentile (children)
  13. Smoking/vaping.
  14. Alcohol intake above a UK National Health Service (NHS) questionnaire cut-off.
  15. Regular use of recreational drugs.
  16. Not having reached menopause (for women aged 53-57 only).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Single arm

    Study participants are asked to undertake the Cornell treadmill exercise protocol which they complete to voluntary exhaustion.

    Device: Cornell treadmill exercise protocol

Interventions

  • DeviceCornell treadmill exercise protocol

    Study participants are asked to undertake the Cornell treadmill exercise protocol which they complete to voluntary exhaustion.

06

What researchers measure

Primary outcomes

  1. Concentration of molecules relating to energy metabolism using targeted liquid chromatography-mass spectrometry assays

    Concentrations of metabolites measured in plasma and saliva at baseline, immediately after exercise and one hour after exercise using targeted liquid chromatography-mass spectrometry (LCMS) assays. These include amine, ion-pairing, lipid, fatty acid, acylcarnitine and oxylipin assays.

    Time frame: At baseline, immediately after exercise and one hour after exercise

Secondary outcomes

  1. Concentrations of hormones relating to life history functions using different assays

    Concentrations of hormones measured in plasma or saliva at baseline, immediately after exercise and one hour after exercise using hormone assays. These hormone assays relate to the four life history functions, maintenance, defence, reproduction and growth. The following assays will be used: Bacteria killing and haemolytic complement assays in plasma to assess resistance to infection, total antioxidant capacity and malondialdehyde assays in plasma to assess oxidative stress, cortisol in saliva to assess stress response, interleukin-6 in saliva to assess inflammation, insulin growth factor and growth hormone assays in saliva to assess growth, oestradiol and testosterone in saliva to assess reproduction, as well as leptin, adiponectin and insulin in saliva to assess energy stores.

    Time frame: At baseline, immediately after exercise and one hour after exercise

  2. Total body water measurement

    Total body water using the doubly-labelled water method which involves collection of saliva before and 4 hours after consuming a dose of deuterium

    Time frame: Saliva collection before and 4 hours following consumption of deuterium

  3. Verbal memory

    Verbal memory assessment using the Rey Auditory Verbal Learning Test (RAVLT)

    Time frame: Baseline, immediately after exercise and one hour after exercise

  4. Measurement of stress, mood, appetite perception, and the desire to eat different types of food

    Assessment of stress, mood, appetite perception, and the desire to eat different types of food using a visual analogue scale published by Stubbs et al, 2000 and adapted online before breakfast, after breakfast as well as 15, 30, 45 and 60 minutes after exercise. This instrument incorporates a straight line in between two opposing statements defined as 'very little' to 'very much'. Participants are asked to mark a point in relation to their feelings at that moment. Stubbs, R. J., Hughes, D. A., Johnstone, A. M., Rowley, E., Reid, C., Elia, M., et al. (2000). The use of visual analogue scales to assess motivation to eat in human subjects: A review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. British Journal of Nutrition, 84, 405e415.

    Time frame: Before breakfast, after breakfast as well as 15, 30, 45 and 60 minutes after exercise

07

Study locations

1 of 1 sites recruiting
  • University of East London SportsDock
    London, E16 2RD, United Kingdom
    Recruiting
08

References and documents

Study documents

  • Informed consent form · Mar 24, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Researchers will have access to fully anonymised data.

Supporting information: Study protocol, Sap, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06088108
Lead sponsor
University College, London
Collaborators
University of East London, Imperial College London
Responsible party
Sponsor
First posted
Oct 18, 2023
Start date
Apr 1, 2023
Primary completion
Jan 31, 2024 (estimated)
Completion
Jan 31, 2024 (estimated)
Last update
Oct 18, 2023

Study contacts

Evelyn Maniaki, Dr
Contact
evelyn.maniaki.20@ucl.ac.uk
+447481306193
Andy Galbraith, Dr
Contact
A.J.Galbraith@uel.ac.uk
Jonathan Wells, Professor
principal investigator · University College, London

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion